Fensolvi Every 6 Months 45 MG per 0.375 ML Prefilled Syringe

RxCUI: 2371773
RxNorm name: Fensolvi Every 6 Months 45 MG per 0.375 ML Prefilled Syringe
Display name: Fensolvi Every 6 Months 45 MG per 0.375 ML Prefilled Syringe
Full name: Fensolvi Every 6 Months 45 MG per 0.375 ML Prefilled Syringe
Term type: SY
Status: DailyMed mapping
Updated: 2026-06-04 23:39:24

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Fensolvi	LEUPROLIDE ACETATE	TOLMAR Inc.	2c311700-edf4-4f2a-a468-9875489a6cc7	2025-09-25	Warnings, Adverse reactions	Exact identifier rxcui: 2371773
Fensolvi	LEUPROLIDE ACETATE	TOLMAR Inc.	dfb6e01c-f138-471d-bf5b-2be38247e3f0	2022-04-28	Warnings, Adverse reactions	Exact identifier rxcui: 2371773

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set ID	RxNorm string	TTY	SPL version	Label	Effective
dfb6e01c-f138-471d-bf5b-2be38247e3f0	Fensolvi Every 6 Months 45 MG per 0.375 ML Prefilled Syringe	SY	17	These highlights do not include all the information needed to use FENSOLVI ® safely and effectively. See full prescribing information for FENSOLVI. FENSOLVI (leuprolide acetate) for injectable suspension, for subcutaneous use Initial U.S. Approval: 1985	20220428
dfb6e01c-f138-471d-bf5b-2be38247e3f0	0.375 ML Fensolvi 120 MG/ML Prefilled Syringe	SY	17	These highlights do not include all the information needed to use FENSOLVI ® safely and effectively. See full prescribing information for FENSOLVI. FENSOLVI (leuprolide acetate) for injectable suspension, for subcutaneous use Initial U.S. Approval: 1985	20220428
dfb6e01c-f138-471d-bf5b-2be38247e3f0	0.375 ML leuprolide acetate 120 MG/ML Prefilled Syringe [Fensolvi]	SBD	17	These highlights do not include all the information needed to use FENSOLVI ® safely and effectively. See full prescribing information for FENSOLVI. FENSOLVI (leuprolide acetate) for injectable suspension, for subcutaneous use Initial U.S. Approval: 1985	20220428
dfb6e01c-f138-471d-bf5b-2be38247e3f0	Fensolvi 45 MG in 0.375 ML (6 month) Prefilled Syringe	PSN	17	These highlights do not include all the information needed to use FENSOLVI ® safely and effectively. See full prescribing information for FENSOLVI. FENSOLVI (leuprolide acetate) for injectable suspension, for subcutaneous use Initial U.S. Approval: 1985	20220428
2c311700-edf4-4f2a-a468-9875489a6cc7	Fensolvi 45 MG in 0.375 ML (6 month) Prefilled Syringe	PSN	12	These highlights do not include all the information needed to use FENSOLVI ® safely and effectively. See full prescribing information for FENSOLVI. FENSOLVI (leuprolide acetate) for injectable suspension, for subcutaneous use Initial U.S. Approval: 1985	20250925
2c311700-edf4-4f2a-a468-9875489a6cc7	Fensolvi Every 6 Months 45 MG per 0.375 ML Prefilled Syringe	SY	12	These highlights do not include all the information needed to use FENSOLVI ® safely and effectively. See full prescribing information for FENSOLVI. FENSOLVI (leuprolide acetate) for injectable suspension, for subcutaneous use Initial U.S. Approval: 1985	20250925
2c311700-edf4-4f2a-a468-9875489a6cc7	0.375 ML leuprolide acetate 120 MG/ML Prefilled Syringe [Fensolvi]	SBD	12	These highlights do not include all the information needed to use FENSOLVI ® safely and effectively. See full prescribing information for FENSOLVI. FENSOLVI (leuprolide acetate) for injectable suspension, for subcutaneous use Initial U.S. Approval: 1985	20250925
2c311700-edf4-4f2a-a468-9875489a6cc7	0.375 ML Fensolvi 120 MG/ML Prefilled Syringe	SY	12	These highlights do not include all the information needed to use FENSOLVI ® safely and effectively. See full prescribing information for FENSOLVI. FENSOLVI (leuprolide acetate) for injectable suspension, for subcutaneous use Initial U.S. Approval: 1985	20250925